Japan· JP-4490027F1227
ロラタジン
A loratadine product containing ロラタジン, registered in Japan by フェルゼンファーマ, on the national reimbursement list. The same ATC class is registered in 18 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Loratadine is registered in 18 of 19 countries.
Countries holding a registration under ATC R06AX13 (loratadine), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 10 of them publish a price we can compare per daily dose
Loratadine · ATC R06AX13
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of loratadine costs, country by country.
Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.18 in France to $0.57 in Switzerland — a ×3.2 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Loratadine · price per daily dose (10 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.57
- IT Italy$0.21
- FR France$0.18
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- ロラタジン
- Manufacturer
- フェルゼンファーマ
- Country
- Japan (JP)
- ATC code
- R06AX13
- ATC class
- Loratadine
- Defined daily dose
- 10 mg, O
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
539 interactions on record for loratadine.
Graded by severity as the source publishes them — 74 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Loratadine · interactions on record
539 records
- 74 moderate
- 12 minor
- 453 info
Most severe, free to view
- TroglitazoneA10BG01moderate
- Glycerol phenylbutyrateA16AX09moderate
- LonafarnibA16AX20moderate
- FostamatinibB02BX09moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under R06AX13
Loratadine, as other registers publish it.
- United States24 / 7 Life Non-Drowsy Allergy ReliefLil' Drug Store Products, Inc.
- United States24 / 7 Life Non-Drowsy Allergy ReliefLil' Drug Store Products, Inc.
- Canada24 HOUR ALLERGY REMEDYVITA HEALTH PRODUCTS INC
- United States365 Whole Foods Market LoratadineWhole Foods Market, Inc.
- NetherlandsAH Hooikoortstabletten Loratadine 10 mg, tablettenSameko Farma B.V.
- United StatesAlavertFoundation Consumer Brands
- United StatesAlavertFoundation Consumer Brands
- United StatesAlavertFoundation Consumer Healthcare
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c5dfd52e-b78a-412e-a9ca-2a6150292879 GET /v1/drugs/c5dfd52e-b78a-412e-a9ca-2a6150292879?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "１０ｍｇ１錠",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "4490027F1227",
"category": "内用薬",
"price_yen": 13.9,
"generic_name": "ロラタジン",
"product_name_jp": null,
"therapeutic_class": "4490",
"transitional_expiry": null
}See everything about loratadine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.